KCNE1 encodes a regulatory subunit of the KCNQ1 potassium channel-complex. Both KCNE1 and KCNQ1 are necessary for normal hearing and cardiac ventricular repolarization. Recessive variants in these genes are associated with Jervell and Lange-Nielson syndrome (JLNS1 and JLNS2), a cardio-auditory syndrome characterized by congenital profound sensorineural deafness and a prolonged QT interval that can cause ventricular arrhythmias and sudden cardiac death.
BACKGROUND
Inherited predisposition to syncopal episodes and sudden death due to cardiac arrhythmias and arrest is a genetically heterogeneous disorder that can be transmitted as a recessive or dominant trait (Huikuri, Castellanos, & Myerburg, 2001; Katritsis, Gersh, & Camm, 2016; Roberts, 2006) . Variants in at least 16 different genes are associated with an abnormal prolongation of ventricular repolarization known as long QT syndrome (LQTS1-LQTS15; MIM# 192500) (Alders & Christiaans, 1993; Grunert, Bodi, & Odening, 2017) . LQTS has an incidence of approximately 1:2,000 births and occurs across various populations (Nakano & Shimizu, 2016; Priori et al., 2003; Priori et al., 2013; Splawski et al., 2000) . Prolongation of the QT interval may also be one feature of a broader phenotype. A case in point is Jervell and Lange-Nielsen syndrome (JLNS, Long QT syndrome 1, LQTS type 1 MIM# 220400), which is inherited in an autosomal recessive manner and characterized by a prolonged QT interval and congenital, profound hearing loss (Jervell & Lange-Nielsen, 1957) . JLNS type 1 is associated with biallelic pathogenic variants of KCNQ1, a gene discovered in a molecular genetic study of prolonged QT, which can be triggered by physical exertion (Neyroud et al., 1997) . KCNQ1 encodes a slowly activating and slowly deactivating delayed-rectifier potassium channel (previous names are KvLQT1, Kv7.1, and KCNA8). KCNQ1 contributes to a potassium current that terminates the cardiac action potential (Priori et al., 2003; Wrobel, Tapken, & Seebohm, 2012) . In the absence of a family history of a prolonged QT interval, the cardiac phenotype of a hearing or deaf individual may remain concealed until a syncopal episode occurs (Schwartz et al., 2001; Wang et al., 1996) . JLNS type 2 (MIM #612347) is a less common cardio-auditory disorder that is also inherited as an autosomal recessive trait and associated with variants of KCNE1. The KCNE family of proteins has five members (KCNE1-KCNE5), all of which are small single-pass integral membrane proteins ranging in size from 103 to 177 residues. KCNE1 protein (previous names are LQT5, mink, and IsK) functions as a regulatory subunit of KCNQ1 (Schulze-Bahr et al., 1997; Splawski, Tristani-Firouzi, Lehmann, Sanguinetti, & Keating, 1997; Tranebjaerg, Samson, & Green, 1993; Tyson et al., 1997) . KCNE1 coassembles into a complex with KCNQ1, calmodulin, and the lipid PIP2 (Sun & MacKinnon, 2017; Zaydman et al., 2013) and modulates the biophysical properties of the channel (Abbott, 2016; Jespersen, Grunnet, & Olesen, 2005; Sanguinetti et al., 1996; Wrobel et al., 2012) . KCNE1 may also associate with other pore-forming alpha subunits, suggesting that the clinical manifestations of missense mutations of KCNE1 may not be limited to disruptions of currents ascribed to KCNQ1 (Abbott & Goldstein, 2002) .
In the inner ear, the stria vascularis is an epithelial tissue that is involved in the formation and maintenance of the endocochlear potential (EP) of +80 mV between the potassium-rich endolymph, a fluid that fills the scala media and bathes the apical surface of hair cells, and the perilymph which bathes the basolateral part of the hair cells ( Figure 1a ). Hair cells are the mechano-chemical transducers of sound. Normal strial function requires both KCNE1 and KCNQ1 for hearing (Kang et al., 2008) . To date, all reported variants of KCNE1 and KCNQ1 that are associated with deafness are recessive; carriers of heterozygous pathogenic variants of KCNE1 and KCNQ1 have normal hearing. Thus, the loss-of-function (LOF) of KCNE1 in the inner ear is not compensated by any of the four KCNE1 paralogs (KCNE2-KCNE5) (McCrossan & Abbott, 2004 (Romano, 1965; Ward, 1964) (Table 1) . A dominant negative mechanism was demonstrated for RWS-associated variants of KCNQ1 and KCNE1. In a heterozygote, wild-type and defective monomers can coassemble to form an impaired KCNQ1 potassium channel complex, which can result in a prolonged QT interval (Schmitt et al., 2000; Splawski et al., 1997) . This paper is focused on variants of KCNE1 and the associated cardiac and auditory phenotypes, and it complements more expansive reviews of inherited and acquired long QT syndromes (Roden & Viswanathan, 2005; Tranebjaerg, Samson, & Green, 2017; Tyson et al., 2000) . Here, we spotlight the current knowledge of variants of KCNE1 associated with isolated long QT of RWS as well as the hearing loss and prolonged-QT of JLNS2. We also describe three previously unreported homozygous recessive, protein-truncating variants of KCNE1 segregating in consanguineous families ascertained for severe to profound deafness, indicating that KCNE1 should be included in screening panels for variants of genes reported to be associated with deafness.
Last, the data reviewed here underscore the importance of a molecular genetic diagnosis, genetic counseling, and a cardiologic assessment of the QT-interval for risk of sudden death for deaf individuals, as well as their heterozygous parents and normal-hearing relatives.
METHODS
The three families in this study (PKDF461, 4410, and 4502) were ascertained in Pakistan. Prior to inclusion, all persons in this study gave their written informed consent to participate. For the protection of human subjects, IRB approvals for this study were obtained from (Figure 2a) , as an initial screen, at least three (green) (c) and KCNE1 (red) (d) to the luminal surface of the marginal cell facing the endolymph. Arrowheads point to examples of colocalization. (e-g) Fluorescent immunohistochemistry of whole mounts of adult mouse stria vascularis depicting colocalization in the overlay (e) of KCNQ1 (green) (f) and KCNE1 (red) (g) on the luminal surface of the marginal cells. Spiral prominence (SP), stria vascularis (SV), phalloidin (Phall). Scale bars correspond to 20 m in all panels microsatellite markers were genotyped per locus to detect possible linkage to one of the reported deafness loci. Subsequently, an additional nineteen chromosome 21q markers were genotyped to refine an interval on chromosome 21q22.12 to 17.6 Mb, including 127 annotated genes and pseudogenes. The exons and flanking intronic DNA were Sanger sequenced for CLDN14 and TMPRSS3, two genes associated unambiguously with congenital nonsyndromic sensorineural hearing loss Wilcox et al., 2001) , as well as TSPEAR, a third gene also located in this 21q interval, but with a debatable association with deafness (Delmaghani et al., 2012; Peled et al., 2016) ( Figure 2b ). Because no likely pathogenic variants were uncovered in the coding sequence of these three chr21q-linked genes, a genomic DNA sample from affected individual V:4 of family PKDF461 was submitted to the New York Genome Center (NYGC) for whole genome sequencing at a mean genome-wide coverage of 30× depth. Sequence reads were mapped against the hg38 human reference sequence using Nearly all of the variants of KCNE1 reported in peer-reviewed articles or databases were identified in subjects ascertained on the basis of a prolonged QT interval. Until the advent of massively parallel sequencing of the human exome and genome, clinicians relied on clinical clues for diagnoses. A small family segregating nonsyndromic hearing loss would most likely not have had further molecular genetic analyses. Since profound congenital deafness is an obvious phenotype, when the hearing status of a subject with long QT was not mentioned, we have assumed for this paper that hearing was within the normal range.
For the majority of variants of KCNE1 reported to be pathogenic for long QT interval, the genotype or mode of inheritance was not specified. When clarification of the genotype was sought but not obtained from a communicating author, here we assumed that a subject was heterozygous for the variant and have classified the phenotype as RWS ( 
np, not provided; #, nomenclature as reported in Splawski et al. (2000) . CADD https://cadd.gs.washington.edu The exact nomenclature for TL58-59PP as reviewed by Mutalyzer is NM_000219.5: p.(Thr58_Leu59delinsProPro). TL58-59PP reported by Tyson et al. (1997) was intended to indicate that prolines replaced threonine and leucine at residues 58 and 59.
performed by the physician using the individual lead with the longest interval. Several formulas have been proposed for heart rate correction of the QT interval. A widely used correction for heart rate is the Bazett's formula that divides the measured QT by the square root of the RR interval (Bazett, 1920) . The Fridericia's formula divides the QT interval by the cube root of the RR interval instead, providing a more accurate correction for both elevated heart rate due to exertion and normal variation in resting heart rate (Friderica, 1920) . Additionally, normal values for corrected QT (QTc) depend on gender and age. The following are the upper limits of a normal QT interval: women, 460 ms; men, 450 ms; and children, 440 ms (Wagner et al., 2009 ). In our study, the QT interval was calculated manually from the start of the QRS complex to the end of the T wave which was determined by using the isoelectric baseline method. ECG tracings have a baseline that represents resting membrane potential and is referred to as the isoelectric line (Al-Khatib, LaPointe, Kramer, & Califf, 2003) . Three consecutive QT intervals were measured and an average QT interval determined.
The QTc interval was calculated using both Bazett and Fridericia formulas.
KCNE1 GENE STRUCTURE AND FUNCTION
The human KCNE1 gene has seven annotated exons but only one is protein-coding (Figure 3a) . Possible divergent biological properties and functions of the five transcription start sites of human KCNE1 remain unexplored (Lundquist et al., 2005) . KCNE1 is a protein of only 129 residues (14.7 kDa) also known as MinK or IsK, which functions as a modulatory -subunit of KCNQ1 Lvov, Gage, Berrios, & Kobertz, 2010) . The extracellular N-terminus of KCNE1 has a conserved N-linked glycosylation site that mediates trafficking to the cell surface (Bas et al., 2011) . (Delmaghani et al., 2012) has been called into question. Homozygosity for this variant was found in normal hearing individuals (Peled et al., 2016) . (c) Representative chromatograms of the genomic DNA sequences of three family members (V:2, IV:6, and V:4) who are homozygous for the reference allele, and heterozygous and homozygous for the KCNE1 c.138C>A variant. The affected codon is shaded in gray is 74.7 kDa (676 residues) and has six-transmembrane domains (Sun & MacKinnon, 2017) . Transmembrane helices S1-S4 are voltage sensors (Tombola, Pathak, & Isacoff, 2006) while S5 and S6 segments form the central pore domain (Sun & MacKinnon, 2017) . Each of the four subunits of KCNQ1 has the potential to bind a KCNE1 subunit but the exact stoichiometry in vivo, that is whether two, three, or four KCNE1 monomers are bound, remains unsettled (Murray et al., 2016; Nakajo, Ulbrich, Kubo, & Isacoff, 2010; Osteen et al., 2010) .
Coexpression of KCNE1 with KCNQ1 increases the outward current amplitude through KCNQ1 by one order of magnitude and also slows its activation by one order of magnitude (Sanguinetti et al., 1996) . The messenger RNAs for all five KCNE paralogs, including KCNE1, are detected in the heart (Lundquist et al., 2005) . In vitro, all five of the KCNE proteins can individually complex with KCNQ1 tetramers and, depending on the cell type, modulate differently the gating kinetics, channel conductance and stability of this flexible potassium channel (Liin et al., 2015; Mazhari, Nuss, Armoundas, Winslow, & Marban, 2002; Murray et al., 2016; Nakajo & Kubo, 2015; Nakajo et al., 2010) .
In cardiomyocytes, channel gating of KCNQ1 is voltage dependent.
However, in the inner ear, KCNQ1 activation is voltage independent, a switch in state that may depend on the interaction of the channel complex with membrane lipids (Liin et al., 2015; Zaydman et al., 2013) .
Whether one of the other four KCNE1 paralogs can partner with KCNQ1 in the heart and partially compensate for the loss of KCNE1 protein is unknown (Osteen et al., 2010) .
VARIANTS OF KCNE1
The nomenclature for DNA and protein sequence variants of KCNE1 described here refers to accession numbers NM_000219.5 and NP_000210.2. Structural models and biochemical, physiological, and genetic analyses have collectively revealed the critical importance of KCNE1 for cardiac and inner ear functions (Abbott, 2016 A sudden unexplained nocturnal death was associated with one variant of KCNE1 ( Figure 3b and (Lai et al., 2002) , an observation that was replicated in the Chinese Han, indicating that "G38S" is a risk factor for atrial fibrillation (Yao, Ma, Xie, Liu, & Chen, 2012) . In two other reports, p.Ser38Gly was labeled as "p.Gly38Ser." Heterozygotes for p.Ser38Gly were reported in ten subjects with a long QT interval of ≥450 ms (Table 1) , though with a minor allele frequency of 0.36, heterozygotes are the most common genotype in the population, assuming Hardy-Weinberg equilibrium. The p.Ser38Gly variant was also reported as a common polymorphism in a cohort from newborn hearing screening (Chang et al., 2014) .
Additionally, there is an aspartic acid at the homologous position in mouse, chimp, rhesus, rat, guinea pig and dog, which indicates a low level of evolutionary conservation of the serine at the 38th residue.
Taken together, p.Ser38Gly appears to be a benign polymorphism.
In contrast, the KCNE1 recurrent variant p. ) and a disputed third deafness locus DFNB98 (TSPEAR) (Delmaghani et al., 2012; Peled et al., 2016) . Sanger sequencing of all annotated exons of TMPRSS3, CLDN14, and TSPEAR did not reveal a coding or splice site variant that might explain the hearing loss segregating in family PKDF461. However, a homozygous noncoding regulatory variant disrupting transcription or splicing of one of these three genes could not be ruled out. Next, we performed whole genome sequencing for affected person V:4. Filtering for rare homozygous variants across the linkage interval, we identified a homozygous nonsense allele in KCNE1 (c.138C>A, p.Tyr46*). We confirmed by Sanger sequencing that this variant was cosegregating with deafness in all available family members (Figure 2c ). Given the role of variants of this gene in JLNS-associated hearing loss, the assumption that the family was segregating nonsyndromic deafness was reconsidered.
The family members did not report a single syncopal episode among of KCNE1 is that one copy of a wild-type KCNE1 allele is sufficient for normal cardiac rhythm. In contrast, forty-two heterozygous substitutions of KCNE1 are reported to be associated with prolonged QT interval (RWS) but not hearing loss (Table 1) . Apparently, KCNQ1 does not function adequately in the presence of certain heterozygous or biallelic amino acid substitutions of KCNE1, which presumably interact with the KCNQ1 tetramer and impairs its function by a dominant negative mechanism (Veitia, Caburet, & Birchler, 2018) . Perhaps in heart, but not in the inner ear, one of the other four KCNE paralogs may partially substitute in the KCNQ1 complex when KCNE1 is absent (Jiang et al., 2009 ).
While ascertaining other families segregating nonsyndromic hearing loss, two more consanguineous families from Pakistan were identified and found to be segregating two additional biallelic truncating variants of KCNE1. Affected members were homozygous for one of two different nucleotide changes in the same codon, c.50G>A and c.51G>A. Both nonsense variants led to the same predicted protein truncation at residue 17 (p.Trp17*; Supp. Figure S1 ). As with PKDF461, family members did not mention cardiac arrhythmia, syncopal episodes, vestibular dysfunction, fainting spells or gross motor development delays. The ages of individuals V:4, V:5, and V:7 who are homozygous mutant for the KCNE1 variant in PKDF461 are 18, 13, and 28 years, respectively. Deaf members of family DEM 4502 did not report any history of sudden deaths, fainting, or cardiologic assessments. However, after identifying the variant of KCNE1 segregating in these two families we attempted to recontact them to inform the family of the molecular genetic data, gather cardiological data but because of a natural disaster that had occurred where they were living, we were unsuccessful.
The American College of Medical Genetics (ACMG) reported 59 medically actionable genes for which incidental findings of pathogenic or likely pathogenic variants should be reported to a patient (Kalia et al., 2017) . Presently, KCNE1 is not listed as one of these 59 genes despite having the same cardiac phenotype as pathogenic variants of KCNQ1. We suggest that KCNE1 be added by the ACMG list because of the same life-threatening risk associated with mutant alleles of KCNE1 as has been reported for KCNQ1.
EXPRESSION OF KCNE1 IN THE STRIA VASCULARIS
In the stria vascularis of the cochlea, the KCNQ1 channel transports potassium ions into the endolymph, which bathes the apical surface of hair cells (Figure 1a) , and contributes to the generation and maintenance of the +80 to +100 mV EP (Wangemann, 1995) . The EP is required for signal transduction and depolarization of hair cells in response to deflection of the stereocilia following basilar membrane movement induced by sound waves. In the marginal cells of the stria vascularis, located in the lateral wall of the organ of Corti (Figure 1b-g ), KCNE1 is required for KCNQ1 channel function (Wangemann, 1995) . From biochemical studies, KCNE2 to KCNE5 each can bind KCNQ1 and alter its channel properties (Abbott, 2016; Jiang et al., 2009 
Kcne1-DEFICIENT MOUSE MODELS
Three different null alleles of mouse Kcne1 have been reported (Table 3) . Two mouse lines have engineered deletions of the single protein-coding exon of Kcne1 (Kupershmidt et al., 1999; Vetter et al., 1996) and the third is a spontaneous p.Arg67* mutation, denoted as Kcne1 pkr for "punk rocker" due to vestibular dysfunction manifested as a head-tossing phenotype (Letts et al., 2000) . Homozygotes for each of the three Kcne1 alleles are deaf, and heterozygotes have normal hearing, recapitulating the auditory phenotype of humans with biallelic or heterozygous pathogenic variants of KCNE1 (Kupershmidt et al., 1999; Letts et al., 2000; Vetter et al., 1996) . In the inner ear, homozygous Vetter et al. (1996) Same allele as reported in Vetter et al. (1996) Not evaluated Longer QT interval at slow heart rates and a shorter QT interval at faster heart rates 20 wk Charpentier et al. (1998) Same allele as reported in Vetter et al. (1996) Not evaluated Longer QT at slow heart rates and shorter QT at faster heart rates 3 wk and 12 wk Drici et al. (1998) Same allele as reported in Vetter et al. (1996) Not evaluated Cardiac arrhythmogenicity 3-6 mth Balasubramaniam et al. (2003) Coding exon of Kcne1 deleted and substituted with a LacZ cassette Not evaluated No prolonged QT interval at slow or fast heart rates Neonates and adults Kupershmidt et al. (1999) Kcne1 pkr spontaneous C>T (p.Arg67*) Deaf, circling, head tossing Not evaluated 5 wk Letts et al. (2000) wk, week; mth, month; P, postnatal; LacZ, encoding E. coli -galactosidase, subsequently show degeneration of hair cells, confirming the importance of the role of KCNE1 in the mouse auditory system (Vetter et al., 1996) .
Conclusions about a cardiac phenotype in the three Kcne1 mutant mouse models are less clear and differ among studies, perhaps for technical reasons. In one Kcne1 knockout mouse line, Drici et al. (1998) reported longer QT intervals at slow heart rates and a shorter QT interval at fast heart rates, similar to what we observed in one male subject of family PKDF461 who was tested both at rest and after exercise, as described above. In contrast, Charpentier, Merot, Riochet, Le Marec, and Escande (1998) reported a QT interval for the same Kcne1 knockout mouse line that was indistinguishable from a wildtype mouse, but they used microelectrodes to measure cardiac function in a restricted area of the myocardium. A third group reported that this same mouse model shows increased cardiac arrhythmogenicity after programmed electrical stimulation (Balasubramaniam, Grace, Saumarez, Vandenberg, & Huang, 2003) . Kupershmidt et al. (1999) did not observe differences in ECGs in their independent mouse model compared to wild-type controls. Cardiac rhythm in the Kcne1 pkr mice was not tested (Letts et al., 2000) . Regardless of any cardiac phenotypic differences among studies of homozygous mutant mice, the mouse has a normal heart rate of 500-700 bpm (Ho et al., 2011) . Such a high bpm increases the technical challenge of accurately measuring QT intervals, and further suggests that in some cases the mouse may not be a suitable model for human cardiac arrhythmias. In contrast, the inner ears of human and mouse are architecturally and functionally very similar to one another (Friedman, Dror, & Avraham, 2007) . Mouse models of human hereditary deafness have been used extensively to study in vivo function of these genes.
MANAGEMENT AND CONCLUSIONS
The co-occurrence of profound hearing loss and a prolonged QT inter- Finally, KCNE1 and KCNQ1 should be added to the panel of deafness genes that are screened commercially and in academic institutions for patients assumed initially to have nonsyndromic deafness.
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